Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double‐blind placebo‐controlled trial

• Published in: BJOG : an international journal of obstetrics and gynaecology 2021-11, Vol.128 (12), p.2024-2033
• Main Authors: Ewies, AAA, Ahmed, I, Al‐Azzawi, F, Pitkin, J, Gupta, P, Persic, M, Sahu, B, Elgobashy, A, Barraclough, L, Woodman, J, Babrah, J, Bowden, S, Stocken, D, Billingham, L, Sundar, S, Rea, D
• Format: Article
• Language: English
• Subjects: Acids; Dietary supplements; Double-blind studies; Emotions; Folic acid; hot flushes; Menopause; Placebos; Post-menopause; Quality of life; Statistical analysis; Supplements; Vitamin B; Womens health
• ISSN: 1470-0328; 1471-0528
• DOI: 10.1111/1471-0528.16739

Objective To assess whether folic acid supplementation ameliorates hot flushes. Design Double‐blind, placebo‐controlled randomised trial. Setting Nine hospitals in England. Population Postmenopausal women experiencing ≥50 hot flushes weekly. Methods Women (n = 164) were randomly assigned in a 1:1 ratio to receive folic acid 5 mg tablet or placebo daily for 12 weeks. Participants recorded frequency and severity of hot flushes in a Sloan Diary daily and completed Greene Climacteric and Utian Quality of Life (UQoL) Scales at 4‐week intervals. Main outcome measures The change in daily Hot Flush Score at week 12 from randomisation based on Sloan Diary Composite Score B calculation. Results Data of 143 (87%) women were available for the primary outcome. The mean change (SD) in Hot Flush Score at week 12 was −6.98 (10.30) and −4.57 (9.46) for folic acid and placebo group, respectively. The difference between groups in the mean change was −2.41 (95% CI −5.68 to 0.87) (P = 0.149) and in the adjusted mean change −2.61 (95% CI −5.72 to 0.49) (P = 0.098). Analysis of secondary outcomes indicated an increased benefit in the folic acid group regarding changes in total and emotional UQoL scores at week 8 when compared with placebo. The difference in the mean change from baseline was 5.22 (95% CI 1.16–9.28) and 1.88 (95% CI 0.23–3.52) for total and emotional score, respectively. Conclusions The study was not able to demonstrate that folic acid had a statistically significant greater benefit in reducing Hot Flush Score over 12 weeks in postmenopausal women when compared with placebo. Tweetable Folic acid may ameliorate hot flushes in postmenopausal women but confirmation is required from a larger study. Tweetable Folic acid may ameliorate hot flushes in postmenopausal women but confirmation is required from a larger study.